138 related articles for article (PubMed ID: 3621669)
1. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.
Taverne J; Tavernier J; Fiers W; Playfair JH
Clin Exp Immunol; 1987 Jan; 67(1):1-4. PubMed ID: 3621669
[TBL] [Abstract][Full Text] [Related]
2. Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.
De Titto EH; Catterall JR; Remington JS
J Immunol; 1986 Aug; 137(4):1342-5. PubMed ID: 3525677
[TBL] [Abstract][Full Text] [Related]
3. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
Taverne J; Matthews N; Depledge P; Playfair JH
Clin Exp Immunol; 1984 Aug; 57(2):293-300. PubMed ID: 6467675
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.
Clark IA; Hunt NH; Butcher GA; Cowden WB
J Immunol; 1987 Nov; 139(10):3493-6. PubMed ID: 3119710
[TBL] [Abstract][Full Text] [Related]
5. Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages.
Ockenhouse CF; Shear HL
J Immunol; 1984 Jan; 132(1):424-31. PubMed ID: 6690606
[TBL] [Abstract][Full Text] [Related]
6. Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.
Sheikh NA; Caro HN; Taverne J; Playfair JH; Rademacher TW
Immunology; 1996 Mar; 87(3):461-6. PubMed ID: 8778034
[TBL] [Abstract][Full Text] [Related]
7. A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.
Kumaratilake LM; Rathjen DA; Mack P; Widmer F; Prasertsiriroj V; Ferrante A
J Clin Invest; 1995 May; 95(5):2315-23. PubMed ID: 7738194
[TBL] [Abstract][Full Text] [Related]
8. The liver stage of Plasmodium berghei inhibits host cell apoptosis.
van de Sand C; Horstmann S; Schmidt A; Sturm A; Bolte S; Krueger A; Lütgehetmann M; Pollok JM; Libert C; Heussler VT
Mol Microbiol; 2005 Nov; 58(3):731-42. PubMed ID: 16238623
[TBL] [Abstract][Full Text] [Related]
9. Selected problems of malaria blood stage immunity.
Perlmann P; Perlmann H; Berzins K; Troye-Blomberg M
Tokai J Exp Clin Med; 1998 Apr; 23(2):55-62. PubMed ID: 10021776
[TBL] [Abstract][Full Text] [Related]
10. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.
Bate CA; Taverne J; Román E; Moreno C; Playfair JH
Immunology; 1992 Jan; 75(1):129-35. PubMed ID: 1537589
[TBL] [Abstract][Full Text] [Related]
12. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
13. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
14. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro.
Muniz-Junqueira MI; dos Santos-Neto LL; Tosta CE
Cell Immunol; 2001 Mar; 208(2):73-9. PubMed ID: 11333139
[TBL] [Abstract][Full Text] [Related]
15. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
[TBL] [Abstract][Full Text] [Related]
16. [The possible modes of action of TNF (tumor necrosis factor)].
Orita K
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1379-86. PubMed ID: 6742864
[TBL] [Abstract][Full Text] [Related]
17. Massive destruction of malaria-parasitized red blood cells despite spleen closure.
Krücken J; Mehnert LI; Dkhil MA; El-Khadragy M; Benten WP; Mossmann H; Wunderlich F
Infect Immun; 2005 Oct; 73(10):6390-8. PubMed ID: 16177310
[TBL] [Abstract][Full Text] [Related]
18. Lymphotoxin alpha and tumour necrosis factor are not required for control of parasite growth, but differentially regulate cytokine production during Plasmodium chabaudi chabaudi AS infection.
Clark K; Kulk N; Amante F; Haque A; Engwerda C
Parasite Immunol; 2007 Mar; 29(3):153-8. PubMed ID: 17266742
[TBL] [Abstract][Full Text] [Related]
19. [Definition of tumor-necrosis factor and its production mechanism].
Urushizaki I; Niitsu Y; Watanabe N
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
[TBL] [Abstract][Full Text] [Related]
20. Antiparasitic effects of tumour necrosis factor in vivo and in vitro.
Playfair JH; Taverne J
Ciba Found Symp; 1987; 131():192-205. PubMed ID: 3131074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
